Surface Oncology, Inc.
Anti-CD112R Compositions and Methods
Last updated:
Abstract:
The invention provides anti-CD112R antibody compositions and their use in treating cancer.
Status:
Application
Type:
Utility
Filling date:
19 Nov 2021
Issue date:
26 May 2022